From Wikipedia, the free encyclopedia
6PGD
Crystallographic structure of sheep 6-phosphogluconate dehydrogenase complexed with adenosine 2'-monophosphate [1]
Identifiers
Symbol6PGD
Pfam PF00393
Pfam clan CL0106
InterPro IPR006114
PROSITE PDOC00390
SCOP2 2pgd / SCOPe / SUPFAM
Available protein structures:
Pfam   structures / ECOD  
PDB RCSB PDB; PDBe; PDBj
PDBsum structure summary
Phosphogluconate dehydrogenase
6-phosphogluconate dehydrogenase dimer, Ovis aries
Identifiers
EC no. 1.1.1.44
CAS no. 9001-82-5
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / QuickGO
Search
PMC articles
PubMed articles
NCBI proteins
phosphogluconate dehydrogenase
Identifiers
SymbolPGD
NCBI gene 5226
HGNC 8891
OMIM 172200
RefSeq NM_002631
UniProt P52209
Other data
EC number 1.1.1.44
Locus Chr. 1 p36.3-36.13
Search for
Structures Swiss-model
Domains InterPro

6-Phosphogluconate dehydrogenase (6PGD) is an enzyme in the pentose phosphate pathway. It forms ribulose 5-phosphate from 6-phosphogluconate:

6-phospho-D-gluconate + NAD(P)+ D-Ribulose 5-phosphate + CO2 + NAD(P)H + H+

It is an oxidative carboxylase that catalyses the oxidative decarboxylation of 6-phosphogluconate into ribulose 5-phosphate in the presence of NADP. This reaction is a component of the hexose mono-phosphate shunt and pentose phosphate pathways (PPP). [2] [3] Prokaryotic and eukaryotic 6PGD are proteins of about 470 amino acids whose sequences are highly conserved. [4] The protein is a homodimer in which the monomers act independently: [3] each contains a large, mainly alpha-helical domain and a smaller beta-alpha-beta domain, containing a mixed parallel and anti-parallel 6-stranded beta sheet. [3] NADP is bound in a cleft in the small domain, the substrate binding in an adjacent pocket. [3]

Biotechnological significance

Recently, 6PGD was demonstrated to catalyze also the reverse reaction (i.e. reductive carboxylation) in vivo. [5] Experiments using Escherichia coli selection strains revealed that this reaction was efficient enough to support the formation of biomass based solely on CO2 and pentose sugars. In the future, this property could be exploited for synthetic carbon fixation routes.

Clinical significance

Mutations within the gene coding this enzyme result in 6-phosphogluconate dehydrogenase deficiency, an autosomal hereditary disease affecting the red blood cells.

As a possible drug target

6PGD is involved in cancer cell metabolism so 6PGD inhibitors have been sought. [6]

See also

References

  1. ^ PDB: 1PGQ​; Adams MJ, Ellis GH, Gover S, Naylor CE, Phillips C (July 1994). "Crystallographic study of coenzyme, coenzyme analogue and substrate binding in 6-phosphogluconate dehydrogenase: implications for NADP specificity and the enzyme mechanism". Structure. 2 (7): 651–68. doi: 10.1016/s0969-2126(00)00066-6. PMID  7922042.
  2. ^ Broedel SE, Wolf RE (July 1990). "Genetic tagging, cloning, and DNA sequence of the Synechococcus sp. strain PCC 7942 gene (gnd) encoding 6-phosphogluconate dehydrogenase". J. Bacteriol. 172 (7): 4023–31. doi: 10.1128/jb.172.7.4023-4031.1990. PMC  213388. PMID  2113917.
  3. ^ a b c d Adams MJ, Archibald IG, Bugg CE, Carne A, Gover S, Helliwell JR, Pickersgill RW, White SW (1983). "The three dimensional structure of sheep liver 6-phosphogluconate dehydrogenase at 2.6 A resolution". EMBO J. 2 (6): 1009–14. doi: 10.1002/j.1460-2075.1983.tb01535.x. PMC  555222. PMID  6641716.
  4. ^ Reizer A, Deutscher J, Saier MH, Reizer J (May 1991). "Analysis of the gluconate (gnt) operon of Bacillus subtilis". Mol. Microbiol. 5 (5): 1081–9. doi: 10.1111/j.1365-2958.1991.tb01880.x. PMID  1659648. S2CID  2006623.
  5. ^ Satanowski A, Dronsella B, Noor E, Vögeli B, He H, Wichmann P, et al. (November 2020). "Awakening a latent carbon fixation cycle in Escherichia coli". Nature Communications. 11 (1): 5812. Bibcode: 2020NatCo..11.5812S. doi: 10.1038/s41467-020-19564-5. PMC  7669889. PMID  33199707.
  6. ^ 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1–AMPK signalling. 2015

Further reading

This article incorporates text from the public domain Pfam and InterPro: IPR006114